First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: In-house study and systematic review

Placenta

Volumn 33, Issue 9, 2012, Pages 735-740

  Schneuer, F J ^a   Nassar, N ^a   Khambalia, A Z ^a   Tasevski, V ^a,b   Ashton, A W ^a   Morris, J M ^a   Roberts, C L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Biological markers; First trimester; Placental protein 13; Pregnancy; Prenatal diagnosis

Indexed keywords

PLACENTA PROTEIN; PLACENTA PROTEIN 13; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; FIRST TRIMESTER PREGNANCY; HUMAN; META ANALYSIS; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; SCREENING TEST; SMALL FOR DATE INFANT; SYSTEMATIC REVIEW;

BIOLOGICAL MARKERS; FEMALE; GALECTINS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; MASS SCREENING; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; SENSITIVITY AND SPECIFICITY;

EID: 84865233405     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2012.05.012     Document Type: Article

References (35)

1. H. Bohn, W. Kraus, and W. Winckler Purification and characterisation of two new soluble placental tissue proteins (PP13 and PP17) Oncodev Biol Med 4 1983 343 350 (Pubitemid 13078219)
2. H.J. Kliman, M. Sammar, Y.I. Grimpel, S.K. Lynch, K.M. Milano, and E. Pick Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia Reprod Sci 19 1 2012 16 30
3. N. Than, B. Sumegi, G.N. Than, Z. Berente, and H. Bohn Isolation and sequence analysis of a cDNA encoding human placental tissue protein 13 (PP13), a new lysophospholipase, homologue of human eosinophil Charcot-Leyden crystal protein Placenta 20 1999 703 710 (Pubitemid 29479016)
4. K. Orendi, M. Gauster, G. Moser, H. Meiri, and B. Huppertz Effects of vitamins C and E, acetylsalicylic acid and heparin on fusion, beta-hCG and PP13 expression in BeWo cells Placenta 31 5 2010 431 438
5. A. Sekizawa, Y. Purwosunu, S. Yoshimura, M. Nakamura, H. Shimizu, and T. Okai PP13 mRNA expression in trophoblasts from preeclamptic placentas Reprod Sci 16 4 2009 408 413
6. N.G. Than, E. Pick, S. Bellyei, A. Szigeti, O. Burger, and Z. Berente Than GN and Sumegi B. Functional analyses of placental protein 13/galectin-13 Eur J Biochem/FEBS 271 6 2004 1065 1078 (Pubitemid 38373040)
7. I. Chafetz, I. Kuhnreich, M. Sammar, Y. Tal, Y. Gibor, and H. Meiri First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction Am J Obstet Gynecol 197 1 2007 35 37
8. R. Gonen, R. Shahar, Y.I. Grimpel, I. Chefetz, M. Sammar, and H. Meiri Placental protein 13 as an early marker for pre-eclampsia: a prospective longitudinal study BJOG 115 12 2008 1465 1472
9. G. Karagiannis, R. Akolekar, R. Sarquis, D. Wright, and K.H. Nicolaides Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks Fetal Diagn Ther 29 2 2011 148 154
10. A. Khalil, N.J. Cowans, K. Spencer, S. Goichman, H. Meiri, and K. Harrington First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk Ultrasound Obstet Gynecol 35 6 2010 671 679
11. K.H. Nicolaides, R. Bindra, O.M. Turan, I. Chefetz, M. Sammar, and H. Meiri A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound Ultrasound Obstet Gynecol 27 1 2006 13 17 (Pubitemid 43129084)
12. A.O. Odibo, Y. Zhong, K.R. Goetzinger, L. Odibo, J.L. Bick, and C.R. Bower First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia Placenta 2011
13. R. Romero, J.P. Kusanovic, N.G. Than, O. Erez, F. Gotsch, and J. Espinoza First-trimester maternal serum PP13 in the risk assessment for preeclampsia Am J Obstet Gynecol 199 2 2008 122.e1 122.e11
14. K. Spencer, N.J. Cowans, I. Chefetz, J. Tal, and H. Meiri First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia Ultrasound Obstet Gynecol 29 2 2007 128 134 (Pubitemid 46326583)
15. E.J. Wortelboer, M.P. Koster, H.S. Cuckle, P.H. Stoutenbeek, P.C. Schielen, and G.H. Visser First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia BJOG 117 11 2010 1384 1389
16. R. Akolekar, A. Syngelaki, J. Beta, R. Kocylowski, and K.H. Nicolaides Maternal serum placental protein 13 at 11-13 weeks of gestation in preeclampsia Prenat Diagn 29 12 2009 1103 1108
17. F. Audibert, I. Boucoiran, N. An, N. Aleksandrov, E. Delvin, and E. Bujold Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women Am J Obstet Gynecol 203 4 2010 383.e1 383.e8
18. G. Di Lorenzo, M. Ceccarello, V. Cecotti, L. Ronfani, L. Monasta, and L.V. Brumatti First trimester maternal serum PIGF, free beta-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of preeclampsia Placenta 2012
19. A. Stamatopoulou, N.J. Cowans, E. Matwejew, C. con Kasienberg, and K. Spencer Placental protein-13 and pregnancy-associated plasma protein-A as first trimester screening markers for hyptertensive disorders and small for gestational age outcomes Hypertens Pregnancy 1 2010 1 12
20. Centre for Health Record Linkage Quality assurance in record linkage 2009 http://www.cherel.org.au/CHeReLQualityAssuranceJuly2008.pdf
21. J.B. Ford, C.L. Roberts, C.S. Algert, J.R. Bowen, B. Bajuk, and D.J. Henderson-Smart Using hospital discharge data for determining neonatal morbidity and mortality: a validation study BMC Health Serv Res 7 2007 188
22. N. Meray, J.B. Reitsma, A.C. Ravelli, and G.J. Bonsel Probabilistic record linkage is a valid and transparent tool to combine databases without a patient identification number J Clin Epidemiol 60 9 2007 883 891
23. M.A. Brown, M.D. Lindheimer, M. de Swiet, A. Van Assche, and J.M. Moutquin The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 1 2001 IX XIV
24. C.L. Roberts, and P.A. Lancaster National birthweight percentiles by gestational age for twins born in Australia J Paediatr Child Health 35 3 1999 278 282 (Pubitemid 29282278)
25. Centre for Epidemiology and Research NSWDoH New south wales mothers and babies 2007 2010 NSW Public Health Bull 21(S1)
26. H.S. Cuckle, and N.J. Wald Principles of screening N. Wald, I. Leck, Antenatal & neonatal screening 2nd ed. 2000 Oxford University Press Oxford 3 22
27. J.A. Swets Measuring the accuracy of diagnostic systems Science 240 4857 1988 1285 1293
28. S. Cha Calculate sensitivity and specificity: mayo clinic college of medicine 2005 http://cancercenter.mayo.edu/mayo/research/biostat/upload/senspe. sas (SAS Macro)
29. R. Akolekar, A. Syngelaki, R. Sarquis, M. Zvanca, and K.H. Nicolaides Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks Prenat Diagn 31 1 2011 66 74
30. C.L. Roberts, J.C. Bell, J.B. Ford, R.M. Hadfield, C.S. Algert, and J.M. Morris The accuracy of reporting of the hypertensive disorders of pregnancy in population health data Hypertens Pregnancy 27 3 2008 285 297
31. N.J. Cowans, A. Stamatopoulou, A. Khalil, and K. Spencer PP13 as a marker of pre-eclampsia: a two platform comparison study Placenta 32 Suppl. 2011 S37 S41
32. J.J. Deeks Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests BMJ 323 7305 2001 157 162 (Pubitemid 32678396)
33. I. Cetin, B. Huppertz, G. Burton, H. Cuckle, R. Gonen, and O. Lapaire Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 32 Suppl. 2011 S4 S16
34. N.G. Than, O. Abdul Rahman, R. Magenheim, B. Nagy, T. Fule, and B. Hargitai Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome Virchows Archiv: Int J Pathology 453 4 2008 387 400
35. P. Paiva, C. Whitehead, B. Saglam, K. Palmer, and S. Tong Measurement of mRNA transcripts of very high placental expression in maternal blood as biomarkers of preeclampsia J Clin Endocrinol Metab 96 11 2011 E1807 E1815